Masahito Kawazu

The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies

Shogo Kumagai, Yosuke Togashi, Takahiro Kamada et al. · Nature Immunology · 2020 · 785 citations

Cancer Immunosurveillance, Autoimmune Disease, T-regulatory Cell +12

Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments

Shogo Kumagai, Shohei Koyama, Kota Itahashi et al. · Cancer Cell · 2022 · 752 citations

Cancer Immunosurveillance, Pd-1 Expression, Medicine +11

Prospective Comparison of the Diagnostic Potential of Real-Time PCR, Double-Sandwich Enzyme-Linked Immunosorbent Assay for Galactomannan, and a (1→3)-β- <scp>d</scp> -Glucan Test in Weekly Screening for Invasive Aspergillosis in Patients with Hematological Disorders

Masahito Kawazu, Yoshinobu Kanda, Yasuhito Nannya et al. · Journal of Clinical Microbiology · 2004 · 280 citations · Full text

An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells

Shogo Kumagai, Yosuke Togashi, Chika Sakai et al. · Immunity · 2020 · 239 citations · Full text

Cancer Immunosurveillance, Oncogenic Alteration, Oncogenic Agent +11

Histone Demethylase JMJD2B Functions as a Co-Factor of Estrogen Receptor in Breast Cancer Proliferation and Mammary Gland Development

Masahito Kawazu, Kayoko Saso, Kit I. Tong et al. · PLoS ONE · 2011 · 199 citations · Full text

Histone Modifications, Breast Oncology, Epigenetic Change +25